MedTrace Logo

Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers

NCT01657318 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2018-08-14

No results posted yet for this study

Summary

In this study, the investigators hypothesize that the use of olivamine-containing products in the management of patients with compromised nonhealing lower extremity ulcers is feasible in the Philippine setting. It will result in complete ulcer healing or wound closure after 16 weeks.

Conditions

  • Ulcer
  • Skin Ulcer
  • Leg Ulcer
  • Diabetic Foot

Interventions

OTHER

Olivamine containing wound care products

Continuous wound care with Olivamine containing products until wound closure. Intake of dietary supplement of 1 capsule for 60 days.

Sponsors & Collaborators

  • Pinnaclife Inc.

    collaborator INDUSTRY

  • De La Salle University Medical Center

    lead OTHER

Principal Investigators

  • Michael M Lawenko, MD, FPCS · De La Salle University Medical Center

  • Melchor V. Frias, MD · De La Salle Health Sciences Institute

  • Renato CA Ocampe, MD, FPCS · De La Salle University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-01
Primary Completion
2013-01-30
Completion
2013-02-15

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01657318 on ClinicalTrials.gov